1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow FSHD1: new trials by email Literature Review of FSHD1 trials Research Report on FSHD1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD AOC-1020, Placebo - Facioscapulohumeral Muscular Dystrophy, FSHD | Phase 3 | Recruiting | Avidity Biosciences, Inc. | 200 | 2025-06-10 | 2026-07-27 |
Facioscapulohumeral Muscular Dystrophy 1B (1) · Facioscapulohumeral muscular dystrophy 1a (1) · Muscular Dystrophy, Facioscapulohumeral (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Muscular Diseases (1) · Muscular Disorders, Atrophic (1) · Muscular Dystrophies (1) · Musculoskeletal Diseases (1) · Nervous System Diseases (1) · Neuromuscular Diseases (1)
Sodium Chloride (1)
Canada (1) · Denmark (1) · France (1) · Germany (1) · Italy (1) · Japan (1) · Netherlands (1) · Spain (1) · United Kingdom (1) · United States (1)